Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!

Cresco Capital Partners Raise $60M in Second Funding Round

Cresco Capital Partners Raise $60M in Second Funding RoundNew York-based Cresco Capital Partners, a private equity investment firm dedicated to investing in the cannabis industry, recently announced the closure of its second funding round (CCP Fund II). Cresco Capital Partners was able to raise a cool $60 million in this second funding round. So far, $22 million from CCP Fund II has already been deployed to approximately 15 companies in the cannabis supply chain, from companies which specialize in plant genetics to retail and distribution.

Managing Principal of Cresco Capital Partners, Matthew Hawkins said, “Surpassing our original goal of raising $50 million for CCP Fund II by almost twenty-percent not only represents a significant milestone for Cresco Capital Partners, it serves to validate the leadership role we play in providing growth capital and advisory services to companies within the cannabis industry.”

Since its founding in 2014, Cresco Capital Partners has been able to raise over $85 million in two funding rounds and co-investments. Cresco Capital Partners has its portfolio in diverse companies including MJ Freeway, Harborside/FLRish Inc., NorCal Cannabis Company, PROHBTD, Phylos Biosciences, Sunderstorm, Cellibre, Sublime, and others.

Speaking about Cresco Capital Partners future plans, Hawkins said, “With the overwhelming success of CCP Fund II, we are preparing to begin marketing a third fund in which we hope to raise $200 million. This fund will continue to target investments in value-add opportunities in the legalized cannabis space both plant touching and non-plant touching.”

Critics can easily downplay Cresco Capital Partners exceeding their funding expectation because there is a general boom in cannabis investing. However, for a new investor looking for a progressive cannabis-based investment, this is significant.

Curious about how you can make money investing in cannabis? Sign up for Cannin Free Access and subscribe to the Cannin Chronicle. We’ll keep you informed on all things cannabis and even help you determine which cannabis companies have the highest growth potential.

Cresco Capital Partners Raise $60M in Second Funding Round

About Cannin: Your Marijuana Stock Experts

Cannin is your #1 trusted resource for marijuana and hemp stock investment opportunities. Our global team of experts evaluates all emerging marijuana and hemp stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best marijuana and hemp stock investments for 2020. 

Use Cannin as your resource for:

Is it too late to invest in marijuana or hemp stocks? No! This is the perfect time to invest.

Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in marijuana and hemp stocks is now. Are you looking to buy stock in hemp companies or marijuana companies for 2020? Interested in emerging penny hemp stock companies? Looking for the best Canadian marijuana stocks to invest in? We can help.

Predict price movements of marijuana and hemp stocks several hours in advance with our proprietary algorithmic stock trading software.

  • +25% Gains in 2020
  • +49.8% Gains in 2019
  • Backtested since 2012

We’re so confident you’ll love our signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best marijuana stocks – we’ll show you how at cannin.com

Can we start writing exclusively about Hemp-Only companies? These include the following: Charlotte’s Web, GW Pharma, CV Sciences, Canopy Growth, Elixinol, Organigram, GrowLife, Emerald Health, Neptune, Global Hemp Group. Also, please see the attached report with additional hemp only companies with analysis. It’s from last year so the data is not current but worth a look.

Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks to Buy